HWM
GMAB icon

HighMark Wealth Management’s Genmab GMAB Stock Holding History

HighMark Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-222
Closed -$10K – 505
2021
Q3 		$10K Sell
222
-16
-7% -$718 0.01% 248
2021
Q2 		$10K Sell
238
-8
-3% -$309 0.01% 254
2021
Q1 		$8K Sell
246
-122
-33% -$4.59K 0.01% 268
2020
Q4 		$15K Sell
368
-1,823
-83% -$68.1K 0.01% 180
2020
Q3 		$80K Buy
2,191
+1,961
+853% +$70.9K 0.07% 77
2020
Q2 		$8K Buy
+230
New +$6.27K 0.01% 238

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighMark Wealth Management's GMAB Position: Q4 2021 in Review

HighMark Wealth Management sold out of Genmab (GMAB) in Q4 2021, closing a stake of 222 shares — an estimated $10K sold.

HighMark Wealth Management first reported a position in GMAB in Q2 2020 and held it in 6 quarters. The position peaked at $80K in Q3 2020. 211 funds tracked by Wall St. Rank hold GMAB as of Q4 2021.

  • HighMark Wealth Management reported no remaining Genmab position as of Q4 2021 after selling out during the quarter.
  • HighMark Wealth Management sold 222 Genmab shares in Q4 2021, an estimated $10K.
  • HighMark Wealth Management first reported a position in Genmab in Q2 2020 and held it in 6 quarters.
  • HighMark Wealth Management's Genmab position peaked at $80K in Q3 2020.
  • 211 funds tracked by Wall St. Rank held Genmab as of Q4 2021.

Based on HighMark Wealth Management's 13F filing for Q4 2021, filed 20 Jan 2022.